• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    High Purity New England Bolsters Biopharma Solutions Services

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    Covectra Introduces Next-Gen Serialization Solution
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    C2 Pharma Completes Multiple Regulatory Filings

    Bormioli Opens New Glass Research Center

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK

    Pfizer Partners with Medicines Manufacturing Innovation Center

    CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing

    Stevanato Group Launches AI Platform
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Baxter BioPharma Solutions

    test company saurabh

    PCI Pharma Services

    Reed-Lane
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene

    Adare Pharma Solutions

    Aphena Pharma Solutions

    Almac Group

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    The Struggle with Clinical Study Budgeting

    Industry survey reports problems with accuracy and efficiency

    Related CONTENT
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Solving the Pharma Talent Crunch
    • Hovione Starts Phase 1 Clinical Trial of HY02
    • Akebia Therapeutics Names CMO
    • Selexis SA and OSE Immunotherapeutics Enter Pact
    Andrew Grygiel10.11.11
    Take a Phase II oncology study, with lung cancer as the indication being studied. Clinical operations, working with R&D finance, prepares a detailed study budget that turns out to be approximately $10 million.

    The study is completed 420 days later. R&D finance compares the actual study cost against the study budget, and finds it cost $1.1 million more than planned — enough to fund an entire Phase I study.

    An aberration? Hardly. This represents a typical scenario for nearly half (45%) of the life sciences professionals who responded to a recent industry survey on study budgeting practices and metrics (see sidebar). Charged with forecasting and budgeting clinical studies at biopharmaceutical and medical device companies, these professionals reported that their typical variance — from forecast to actual costs — for clinical studies was at least 11%, and was often greater. And an astonishing one in five stated their cost variance was 16% or more.

    Note that this variance can easily be negative as well, something which is equally disturbing to management. Overestimating the cost of clinical studies means that funds are not being allocated efficiently, leading to wasted resources and a higher opportunity cost.

    Perhaps not surprisingly, respondents also demonstrated a marked lack of confidence in the accuracy of their study budgets, with only 21% stating they were “highly confident” in their budget forecasts. The remainder were either “somewhat confident” (69%) or “not confident” (10%).

    Do large companies (defined in the survey as having at least $1 billion in annual revenue) fare better? The answer is yes — but not by much. Of the respondents from large companies, 40% reported a budget variance of at least 11%, with several reporting variances of 20% or greater. And those that were “highly confident” in their budget forecasting rose just two percentage points, to 23%.

    Mid-sized companies ($100 million to $1 billion in annual revenue) tracked closely with large companies when it came to variances from plan to actual costs; however only 19% of respondents from mid-sized companies were “highly confident” in their budgeting accuracy. And of the respondents from small companies (less than $100 million in annual revenue), 50% reported a budget variance of at least 11%, while 20% were “highly confident” in their budget forecasts.

    Not Only Inaccurate, but Inefficient as Well

    Another notable gap uncovered by the survey was in planning efficiency. Only 16% of all respondents were able to create a ballpark budget for a clinical study in less than a week, with half of respondents requiring three weeks or more. Large companies actually fared worse in planning efficiency, with only 9% able to prepare a ballpark study budget in under one week. Small companies, as might be expected, were more nimble: 24% reported being able to create a ballpark budget in less than a week.

    This inability to conduct study budgeting activities in a timely fashion extended to the review process, with 65% of respondents requiring five weeks or more to complete the budget review and revision cycle for a single study. And almost one-third of respondents (31%) required at least nine weeks to do so. Again, small companies moved faster: 46% were able to conduct the review and revision cycle in fewer than five weeks, while only 23% of large companies could make the same claim.

    What about companies budgeting multiple studies? It usually falls to R&D finance to roll up individual study budgets into a budget portfolio in order to look at the bigger picture. According to the survey this is a time-consuming process, with 62% of all respondents requiring at least three weeks to build their portfolios. The difference between small and large companies showed itself once again, with 51% of small companies able to build their portfolios in less than three weeks, while just 26% of large companies could.

    Why Is Study Budgeting so Difficult?

    A key finding from the survey points to one possible explanation for this industry struggle to forecast clinical study costs accurately and efficiently. According to the survey, the life sciences industry still lags far behind other industries in the use of purpose-built forecasting and budgeting software.

    When asked their primary tool used for clinical study forecasting and budgeting, 57% of respondents pointed to Microsoft Excel. This is in stark contrast to other industries, such as manufacturing or construction, which have long faced cost and resource pressures and which utilize planning software built around their industry’s unique requirements. In fact, the use of planning spreadsheets uncovered by the survey is at a level last seen in other industries 10 or 15 years ago.

    The results of the survey clearly show that the life sciences industry continues to experience difficulty accurately predicting spending for its most costly area: clinical development. Biopharmaceutical and medical device companies of all sizes are struggling to create accurate clinical study budgets in a timely manner, and cost variances from forecast to actual for clinical studies remain high — in spite of the ongoing industry push for greater efficiency. The wide use of spreadsheets rather than purpose-built software bears the brunt of the burden for these failings.

    There’s no need for this. I personally know companies that are able to forecast studies with 95%-99% accuracy from forecast to actual costs. One clinical program manager for a mid-sized sponsor company told me he was able to deliver a <1% cost variance on a $130 million clinical portfolio by combining good business practices with the right tools (which did not include Excel). Another person, a director of clinical outsourcing for a small biotech, is able to build detailed, accurate study budgets and generate RFPs in a matter of hours — strengthening her negotiating position with CROs and cutting contract closure time from two months to two weeks. So we know it can be done.

    The incentive to be more efficient in study forecasting and budgeting is increasing along with the well-known pressures on the life sciences industry. If the industry is truly serious about improving efficiency in clinical development, study sponsors will need to do more to improve the methods they use.  
    Industry Survey: Clinical Study Budgeting Practices and Metrics Methodology

    The survey was conducted at arm’s length by a third-party firm on behalf of ClearTrial. There was no contact between ClearTrial and the survey respondents.

    Quick Facts
    • Survey conducted between May 18 and June 1, 2011
    • 187 complete responses
    • 115 biopharmaceutical and medical devices companies represented
    • Cross-section of small, mid-sized, and large sponsor companies
    • US, European, and Japanese companies represented
    • Primary functional areas: clinical development; clinical operations; finance; outsourcing

    Complete survey results can be downloaded from http://info.cleartrial.com/budgeting-survey.html.

    Andrew Grygiel is chief marketing officer at ClearTrial, a developer of clinical trial operations software. He can be reached at agrygiel@cleartrial.com.
    Related Searches
    • Development
    • Outsourcing
    • Clinical Trial
    • Manufacturing
    Suggested For You
    Ensuring Quality During the Transfer and Scale Up of Rx Drugs Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    Solving the Pharma Talent Crunch Solving the Pharma Talent Crunch
    Hovione Starts Phase 1 Clinical Trial of HY02 Hovione Starts Phase 1 Clinical Trial of HY02
    Akebia Therapeutics Names CMO  Akebia Therapeutics Names CMO
    Selexis SA and OSE Immunotherapeutics Enter Pact Selexis SA and OSE Immunotherapeutics Enter Pact
    CROS NT Expands Medidata Pact CROS NT Expands Medidata Pact
    Establishments, Identifications, Submissions and Beyond Establishments, Identifications, Submissions and Beyond
    Adents, Microsoft Present Serialization Solution Adents, Microsoft Present Serialization Solution
    CMC Biologics: Growing Through Innovation CMC Biologics: Growing Through Innovation
    Teva Appoints Strategy and Innovation BD Teva Appoints Strategy and Innovation BD
    PAREXEL Creates Customized Biopharm Unit PAREXEL Creates Customized Biopharm Unit
    Tekmira Appoints CFO Tekmira Appoints CFO
    Argenta Appoints CEO Argenta Appoints CEO

    Related Features

    • Analytical Services | Information Technology | Laboratory Testing
      Business Intelligence For (and From) the Lab

      Business Intelligence For (and From) the Lab

      How a digital ecosystem can harness the most data-rich environment in the CDMO.
      Bob Voelkner, VP Sales and Marketing, LabVantage 01.27.21

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Clinical Trials | Information Technology
      The Role of Electronic Monitoring in Maintaining Medication Adherence

      The Role of Electronic Monitoring in Maintaining Medication Adherence

      Digital solutions offer hope to get patients to take their medications properly.
      Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20


    • Information Technology
      You Need Solutions, Digitization is the Answer

      You Need Solutions, Digitization is the Answer

      Cloud technology helps today’s contract manufacturers be agile, transparent and efficient.
      Brian Curran, Senior Vice President of Strategic Growth, MasterControl 10.14.20

    • Information Technology
      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      The proven promise and huge potential of using AI and ML to accelerate drug discovery.
      Lucas Glass, Gary Shorter, and Rajneesh Patil, IQVIA 11.20.19

    • Clinical Trials
      Gene Therapy Trials

      Gene Therapy Trials

      Applications and the limitations of real-world data.
      Karen Ooms, Executive Vice President and Head of Statistics, Quanticate 09.16.19


    • Information Technology
      A Brave New World of Data Integrity

      A Brave New World of Data Integrity

      How modern CMOs are keeping up with stringent regulatory guidelines by embracing advanced laboratory information systems.
      Bob Voelkner, VP Sales and Marketing, LabVantage 06.13.19

    • Clinical Trials | Information Technology
      The New Horizon: Metaprise Analytics in Life Sciences

      The New Horizon: Metaprise Analytics in Life Sciences

      Going beyond enterprise analytics to metaprise analytics—patient-centric systems that create a data driven trial team.
      Michelle Longmire, MD, CEO and Founder, Medable 05.07.19

    • Information Technology
      The Manufacturing Revolution In Medicine

      The Manufacturing Revolution In Medicine

      Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards.
      Petter Moree, OSIsoft, LLC 05.07.19


    • Clinical Trials
      Clinical Trial Feasibility

      Clinical Trial Feasibility

      How to reduce late-stage trial risk with feasibility analysis
      Alan Scott and Denis McMillan, PAREXEL International 04.05.19

    • Clinical Trial Materials | Clinical Trials | Supply Chain
      Optimizing Clinical Supply Management

      Optimizing Clinical Supply Management

      IRT system design strategies to help life science companies cut drug wastage across clinical programs.
      Bart Nicholson, Director of Customer Success for IRT, CRF Bracket 04.05.19

    • Information Technology
      Industry 4.0 in the Pharma Industry

      Industry 4.0 in the Pharma Industry

      Digitization is not a single-handed project.
      Dr. Christian Hanisch, Project Manager Industry 4.0 Pharma, Bosch Packaging Technology 03.06.19


    • Information Technology
      Digitization: Pharma 4.0

      Digitization: Pharma 4.0

      A look at how technology is impacting the pharma industry
      Fatih Kaya and Gerald Buerkle, Vetter Pharma 01.25.19

    • Information Technology
      FDA & Data Integrity

      FDA & Data Integrity

      FDA Publishes Final Guidance on Data Integrity
      Robert Marohn, Director of Quality Business Systems, Kite Pharmaceutical 01.25.19

    • Information Technology | Serialization | Supply Chain
      Serialization Compliance

      Serialization Compliance

      Automated data controls during packaging help improve compliance.
      Miguel Pitarch, Executive Director, Global Serialization, Bristol-Myers Squibb & the Bristol-Myers Squibb Serialization Team 11.13.18

    Trending
    • Catalent Acquires Delphi Genetics
    • Inside A Vaccine Trial
    • Wavelength Pharmaceuticals Acquires Majority Stake In Vanamali Organics
    • Century Therapeutics Significantly Expands Capabilities
    • ICON Acquires Medpass
    Breaking News
    • High Purity New England Bolsters Biopharma Solutions Services
    • AMRI Contributes to Efforts to Increase COVID-19 Vax Supply
    • CatSci Opens New Site in UK
    • Pfizer Partners with Medicines Manufacturing Innovation Center
    • Covectra Introduces Next-Gen Serialization Solution
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Coatings World

    Latest Breaking News From Coatings World

    OQ Chemicals Increases Carboxylic Acids, Esters Prices
    Sensory Analytics Announces Issuance of Broad New Patent Covering Coating Thickness Measurement
    Arkema Reports Full-year 2020 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Japan to Lead APAC Assisted Reproductive Technology Devices Market
    Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification
    FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump
    Contract Pharma

    Latest Breaking News From Contract Pharma

    High Purity New England Bolsters Biopharma Solutions Services
    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply
    CatSci Opens New Site in UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Biden Prioritizes PPP Relief for the Beauty Industry
    Christie Brinkley Joins SBLA Beauty
    Madison Reed Raises $52 Million in Financing Round
    Happi

    Latest Breaking News From Happi

    MAC Cosmetics Launches Foundation
    ACI Unveils New Online Resources
    Sales More Than Double at Madison Reed
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Lowe-Martin Adds 2 KODAK NEXFINITY Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    S-OneLP adds to growing team
    Avery Dennison expands automotive portfolio
    Amberley Labels turns to Kurz for embellishments
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Believe Diapers Launch in U.S.
    Forbes Ranks Rockline Among Best U.S. Employers
    H&V Announces Price Increase
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    NuVasive Nabs Simplify Medical for $150M
    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    RFID Locks Market to Reach $9.93 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login